Dr. Marty Makary

a better match with the circulating virus. There was low natural immunity in the population. And we learned that some of that effect was transient. That is, your baseline risk came back to almost the baseline level after a transient period. We cannot be blind. We have to use a scientific approach. And we do that for every other drug at the FDA, right?

Cures for cancer, you know, and it's for certain types of cancer, that is, not all cancer. And why does it take 10 years for a drug to come to market in the United States? We've got to ask these big questions. So we're streamlining the process every place we can.

Cures for cancer, you know, and it's for certain types of cancer, that is, not all cancer. And why does it take 10 years for a drug to come to market in the United States? We've got to ask these big questions. So we're streamlining the process every place we can.

Cures for cancer, you know, and it's for certain types of cancer, that is, not all cancer. And why does it take 10 years for a drug to come to market in the United States? We've got to ask these big questions. So we're streamlining the process every place we can.

It's the great American ripoff. So what's going on here with these prices? We're getting taken advantage of. I mean, I think they're laughing at us. In other countries, they negotiate, you know, sweetheart deals that the drug companies give them in other countries. So a drug can be one-tenth the price, you know, a drug for $1,100, $1,200 in the United States. Yeah.

It's the great American ripoff. So what's going on here with these prices? We're getting taken advantage of. I mean, I think they're laughing at us. In other countries, they negotiate, you know, sweetheart deals that the drug companies give them in other countries. So a drug can be one-tenth the price, you know, a drug for $1,100, $1,200 in the United States. Yeah.

It's the great American ripoff. So what's going on here with these prices? We're getting taken advantage of. I mean, I think they're laughing at us. In other countries, they negotiate, you know, sweetheart deals that the drug companies give them in other countries. So a drug can be one-tenth the price, you know, a drug for $1,100, $1,200 in the United States. Yeah.

is $88 in London and 100-some in Germany. And so they're laughing at us. Now, Pharma's budget for research and development is about 15% to 20% of their overall revenue. Their budget for marketing is 20% to 30%. So they're spending more on these commercials where everyone's dancing and singing nonstop. I mean, I watch some of these. so-called news shows.

is $88 in London and 100-some in Germany. And so they're laughing at us. Now, Pharma's budget for research and development is about 15% to 20% of their overall revenue. Their budget for marketing is 20% to 30%. So they're spending more on these commercials where everyone's dancing and singing nonstop. I mean, I watch some of these. so-called news shows.

is $88 in London and 100-some in Germany. And so they're laughing at us. Now, Pharma's budget for research and development is about 15% to 20% of their overall revenue. Their budget for marketing is 20% to 30%. So they're spending more on these commercials where everyone's dancing and singing nonstop. I mean, I watch some of these. so-called news shows.

And it's basically a nonstop running pharma advertisement with an occasional insertion of some news. And then we got to go right back to break. And then it's more singing and dancing. Are these claims, are they creating an accurate picture of the claims of the medication?

And it's basically a nonstop running pharma advertisement with an occasional insertion of some news. And then we got to go right back to break. And then it's more singing and dancing. Are these claims, are they creating an accurate picture of the claims of the medication?

And it's basically a nonstop running pharma advertisement with an occasional insertion of some news. And then we got to go right back to break. And then it's more singing and dancing. Are these claims, are they creating an accurate picture of the claims of the medication?

And so we're looking at everything. We're looking at direct-to-consumer ads. Yep. Meaning potentially banning those? We would not ban them, but we have the ability to assess whether or not they're providing an accurate picture for the viewer.

And so we're looking at everything. We're looking at direct-to-consumer ads. Yep. Meaning potentially banning those? We would not ban them, but we have the ability to assess whether or not they're providing an accurate picture for the viewer.

And so we're looking at everything. We're looking at direct-to-consumer ads. Yep. Meaning potentially banning those? We would not ban them, but we have the ability to assess whether or not they're providing an accurate picture for the viewer.

And honestly, I don't even know if these companies are trying to entice people to use their products or they're just channeling money to all the news outlets.

And honestly, I don't even know if these companies are trying to entice people to use their products or they're just channeling money to all the news outlets.

And honestly, I don't even know if these companies are trying to entice people to use their products or they're just channeling money to all the news outlets.

Yeah, it's tricky because on one hand, we believe in the First Amendment. And on the other hand, we don't, as an FDA, we don't want a company to misrepresent their product to the public. I mean, the process that they go through to get approved by the FDA includes a part where they have to show what their claims are to the public. And are they creating a notion